BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cioni M, Nocera A, Tagliamacco A, Basso S, Innocente A, Fontana I, Magnasco A, Trivelli A, Klersy C, Gurrado A, Ramondetta M, Boghen S, Catenacci L, Verrina E, Garibotto G, Ghiggeri GM, Cardillo M, Ginevri F, Comoli P. Failure to remove de novo donor-specific HLA antibodies is influenced by antibody properties and identifies kidney recipients with late antibody-mediated rejection destined to graft loss - a retrospective study. Transpl Int 2019;32:38-48. [PMID: 30076765 DOI: 10.1111/tri.13325] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Yilmaz VT, Dandin O, Kisaoglu A, Avanaz A, Kamaci D, Toru HS, Demiryilmaz I, Koksoy S, Aydinli B, Kocak H. Prognosis and Treatment for Active and Chronic Antibody-Mediated Rejection in Renal Transplant Recipients; Single Center Experience. Transplant Proc 2022:S0041-1345(22)00442-0. [PMID: 35907695 DOI: 10.1016/j.transproceed.2022.03.060] [Reference Citation Analysis]
2 Charnaya O, Levy Erez D, Amaral S, Monos DS. Pediatric Kidney Transplantation—Can We Do Better? The Promise and Limitations of Epitope/Eplet Matching. Front Pediatr 2022;10:893002. [DOI: 10.3389/fped.2022.893002] [Reference Citation Analysis]
3 Pearl M, Weng PL, Chen L, Dokras A, Pizzo H, Garrison J, Butler C, Zhang J, Reed EF, Kim IK, Choi J, Haas M, Zhang X, Vo A, Chambers ET, Ettenger R, Jordan S, Puliyanda D. Long term tolerability and clinical outcomes associated with tocilizumab in the treatment of refractory antibody mediated rejection (AMR) in pediatric renal transplant recipients. Clin Transplant 2022;:e14734. [PMID: 35657013 DOI: 10.1111/ctr.14734] [Reference Citation Analysis]
4 Gebel HM, Bray RA. A diagnostic ‘C’ saw: the ups and downs of C1q testing. Current Opinion in Organ Transplantation 2019;24:402-10. [DOI: 10.1097/mot.0000000000000659] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
5 Fylaktou A, Karava V, Vittoraki A, Zampetoglou A, Papachristou M, Antoniadis N, Iniotaki A, Mitsioni A, Printza N. Impact of de novo donor-specific HLA antibodies on pediatric kidney transplant prognosis in patients with acute declined or stable allograft function. Pediatr Transplant 2022;:e14221. [PMID: 34994049 DOI: 10.1111/petr.14221] [Reference Citation Analysis]